Inventory / revenue moved 221 bp lower
Inventory / revenue changed -221 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed -221 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +0.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +13.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt changed +0.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a zero base.
Research & development changed +3.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed -4.7% from the comparable as-filed period.
Inventory changed -1.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -0.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.